The use of peganum harmala in medicine
Downloads
Peganum harmala, commonly known as wild rue or isiriq, is a traditional medicinal plant widely used in Central Asia, the Middle East, and parts of Europe. It contains biologically active alkaloids such as harmine, harmaline, and harmalol, which exhibit antimicrobial, anti-inflammatory, analgesic, antiparasitic, and neurological effects. In Uzbekistan, Peganum harmala has been used in folk medicine for centuries for treating respiratory diseases, digestive disorders, nervous system problems, and spiritual-healing rituals. Modern scientific research also confirms its pharmacological potential, although its toxicity requires careful and controlled use. Medicinal plants play a vital role in traditional and modern healthcare systems across the world. Peganum harmala, known as wild rue or isiriq, is considered one of the most important traditional medicinal plants due to its strong biological activity and wide cultural significance. Historically, it has been used for respiratory infections, digestive problems, nervous disorders, menstrual pain, and skin diseases. Additionally, it is culturally associated with protective rituals against illness and negative energy in many Central Asian societies This article reviews its medicinal importance, traditional applications, pharmacological properties, and relevance in the Uzbek context.
1. Moloudizargari, M., Mikaili, P., Aghajanshakeri, S., Asghari, M. H., & Shayegh, J. (2013). Pharmacological and therapeutic effects of Peganum harmala and its main alkaloids. Avicenna Journal of Phytomedicine, 3(2), 172–178.
2. Herraiz, T., & Guillén, H. (2018). Monoamine oxidase inhibition by harmala alkaloids and their derivatives. Food and Chemical Toxicology, 111, 628–636.
3. Lamchouri, F., et al. (2002). Traditional uses and bioactivity of Peganum harmala. Phytotherapy Research, 16(7), 675–678.
4. Kartal, M., Altun, M. L., & Kurucu, S. (2003). HPLC method for quantification of harmala alkaloids. Journal of Pharmaceutical and Biomedical Analysis, 31(2), 263–269.
5. Monsef, H. R., Ghobadi, A., Iranshahi, M., & Abdollahi, M. (2004). Antinociceptive effects of Peganum harmala. Journal of Ethnopharmacology, 95(2–3), 133–137.
6. Mahmoudian, M., Jalilpour, H., & Salehian, P. (2002). Toxicity of Peganum harmala. Iranian Journal of Pharmacology and Therapeutics, 1(1), 1–4.
7. Ruan, J., et al. (2019). Pharmacokinetics and pharmacology of harmine and harmaline. Frontiers in Pharmacology, 10, 1–10.
8. Singh, S., & Gilca, M. (2010). Herbal medicine and traditional pharmacology: Peganum harmala profile. Journal of Herbal Medicine, 6(3), 150–159.
9. Ben Salah, N., et al. (2017). Antimicrobial and antifungal activity of Peganum harmala extracts. Journal of Applied Microbiology, 123(2), 445–452.
10. Al-Snafi, A. E. (2015). The pharmacological importance of Peganum harmala. IOSR Journal of Pharmacy, 5(3), 64–75.
11. Hamdi, A. (2010). Harmala alkaloids and their neurological effects. Neuroscience Letters, 276(1), 29–33.
12. Torres, M. A., et al. (2016). Antioxidant and anti-inflammatory potential of Peganum harmala seeds. Journal of Ethnopharmacology, 190, 145–153.
13. Asgarpanah, J., & Ramezanloo, F. (2012). Phytochemistry and pharmacological properties of Peganum harmala. African Journal of Pharmacy and Pharmacology, 6(22), 1573–1580.
14. World Health Organization (WHO). (2009). WHO Monographs on Selected Medicinal Plants – Peganum harmala. Geneva.
15. Uzbek Research Institute of Medicinal Plants. (Various years). Studies on traditional use and pharmacological evaluation of Peganum harmala in Uzbekistan. Tashkent: National Herbal Medicine Publications.
